Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs

Annals of Allergy, Asthma and Immunology

Volumn 84, Issue 6, 2000, Pages 613-617

  Quaratino, Donato ^a   Romano, Antonino ^a,b,c   Di Fonso, Marina ^a   Papa, Giuseppe ^a   Perrone, Maria Rosaria ^a   D'Ambrosio, Francesco Purello ^d   Venuti, Alberto ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

^c Unita di Allergologia   (Italy)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; MELOXICAM;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; CROSS REACTION; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; RELIABILITY; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; URTICARIA;

EID: 0033917977     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62412-X     Document Type: Article

References (50)

1. Irey NS. Adverse drug reactions and death. A review of 827 cases. JAMA 1976;236:575-578.
2. Settipane GA, Chafee FH, Klein DE. Aspirin intolerance. II. A prospective study in an atopic and normal population. J Allergy Clin Immunol 1974;53: 200-204.
3. Faich GA. Special report. Adverse-drug-reaction monitoring. N Engl J Med 1986;314:1589-1592.
4. Stevenson DD. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1984;74:617-622.
5. Szczeklik A. Adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. Ann Allergy 1987;59: 113-118.
6. Stevenson DD. Challenge procedures in detection of reactions to aspirin and nonsteroidal anti-inflammatory drugs. Ann Allergy 1993;71:417-418.
7. Czerniawska-Mysik G, Szczeklik A. Idiosyncrasy to pyrazolone drugs. Allergy 1981;36:381-384.
8. De Week AL. Immunological effects of aspirin anhydride, a contaminant of commercial acetylsalicylic acid preparations. Int Arch Allergy 1971;41: 393-418.
9. Blanca M, Perez E, Garcia JJ, et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy 1989;62:295-298.
10. Fernandez-Rivas M, de la Hoz B, Cuevas M, et al. Hypersensitivity reactions to anthranilic acid derivatives. Ann Allergy 1993;71:515-518.
11. Schiavino D, Papa G, Nucera E, et al. Delayed allergy to diclofenac. Contact Dermatitis 1992;26:357-358.
12. Romano A, Pietrantonio F, Di Fonso M, et al. Positivity of patch tests in cutaneous reaction to diclofenac. Allergy 1994;49:57-59.
13. Romano A, Quaratino D, Papa G, et al. Delayed hypersensitivity to diclofenac: a report on two cases. Ann Allergy Asthma Immunol 1998;81: 373-375.
14. Romano A, Pietrantonio F. Delayed hypersensitivity to flurbiprofen. J Intern Med 1997;241:81-83.
15. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971;231:232-235.
16. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1975;1: 67-69.
17. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977; 60:276-284.
18. Samter M, Beers RF. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;68:975-983.
19. Smith AP. Response of aspirin-allergic patients to challenge by some analgesics in common use. Br Med J 1971; 2:494-496.
20. Mathison DA, Stevenson DD. Hypersensitivity to nonsteroidal antiinflammatory drugs: indications and methods for oral challenges. J Allergy Clin Immunol 1979;64:669-674.
21. Carmona MJ, Blanca M, Garcia A, et al. Intolerance to piroxicam in patients with adverse reactions to nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol 1992;90:873-879.
22. Settipane RA, Schrank PJ, Simon RA, et al. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol 1995;96:480-485.
23. Xie W, Chipman JG, Robertson DL, et al. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88: 2692-2696.
24. Vane JR. Towards a better aspirin. Nature New Biol 1994;367:215-216.
25. Spector SL, Wangaard CH, Farr RS. Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J Allergy Clin Immunol 1979;64:500-506.
26. Ispano M, Fontana A, Scibilia J, Ortolani C. Oral challenge with alternative nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen in patients intolerant to these agents. Drugs 1993;46(Suppl. 1):253-256.
27. Bianco S, Robuschi M, Petrigni G, et al. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin. Drugs 1993;46(Suppl 1): 115-120.
28. Andri L, Senna G, Betteli C, et al. Tolerability of nimesulide in aspirin-sensitive patients. Ann Allergy 1994; 72:29-32.
29. Papa G, Romano A, Del Bono A, et al. Floctafenine: a valid alternative in patients with adverse reactions to non steroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 1997;78: 74-78.
30. Quaratino D, Romano A, Papa G, et al. Long-term tolerability of nimesulide and acetaminophen in nonsteroidal anti-inflammatory drug-intolerant patients. Ann Allergy Asthma Immunol 1997;79:47-50.
31. Delaney JC. The diagnosis of aspirin idiosincrasy by analgesic challenge. Clin Allergy 1976;6:177-181.
32. Stricker BH, Meyboom RH, Lindquist M. Acute hypersensitivity reactions to paracetamol. Br Med J 1985;291: 938-939.
33. Settipane RA, Stevenson DD. Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol 1989;84:26-33.
34. Le Van Diem, Grilliat JP. Anaphylactic shock induced by paracetamol. Eur J Clin Pharmacol 1990;38:389-390.
35. Leung R, Plomley R, Czarny D. Paracetamol anaphylaxis. Clin Exp Allergy 1992;22:831-833.
36. Doan T, Greenberger PA. Nearly fatal episodes of hypotension, flushing, and dyspnea in a 47-year-old woman. Ann Allergy 1993;70:439-444.
37. Ownby DR. Acetaminophen-induced urticaria and tolerance of ibuprofen in an eight-year-old child. J Allergy Clin Immunol 1997;99:151-152.
38. Schwarz N, Ham Pong A. Acetaminophen anaphylaxis with aspirin and sodium salicylate sensitivity: a case report. Ann Allergy Asthma Immunol 1996;77:473-474.
39. Noble S, Balfour JA. Meloxicam. Drugs 1996;51:424-430.
40. Pairet M, Engelhardt G. Differential inhibition of COX-1 and COX-2 in vitro and pharmacological profile in vivo of NSAIDs. In: Vane J, Botting J, Botting R, editors. Improved non-steroid anti-inflammalory drugs -COX-2 enzyme inhibitors. Lancaster: Kluwer Academic Publishers and William Harvey Press, 1996:103-119.
41. WHO Pharmaceuticals Newsletter 1998; 5/6:2.
42. Kosnik M, Music E, Matjaz F, Suskovic S. Relative safety of meloxicam in NSAID-intolerant patients. Allergy 1998;53:1231-1233.
43. Vaghi A, De Bernardi G, Grassi N, et al. Tolerance of meloxicam in aspirin-sensitive asthmatics [Abstract]. Am J Respir Crit Care Med 1998;157:A715.
44. Szczeklik A. Mechanism of aspirin-induced asthma. Allergy 1997;52: 613-619.
45. Famaey JP. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Inflamm Res 1997;46:437-446.
46. Stichtenoth DO, Wagner B, Frolich JC. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers. J Invest Med 1997;45:44-49.
47. Blanco FJ, Guitian R, Moreno J, et al. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J Rheumatol 1999;26:1366-1373.
48. Panara MR, Renda G, Sciulli MG, et al. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. J Pharmacol Exp Ther 1999;290:276-280.
49. SIAIC Memorandum on drugs allergy/ intolerance diagnosis. Ital J Allergy Clin Immunol 1998;8:568-595.
50. Falliers CJ. Acetaminophen and aspirin challenges in subgroups of asthmatics. J Asthma 1983;20:39-49.